Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use [PDF]
Case Reports in Ophthalmological Medicine, 2023 Lipid keratopathy (LK) is a rare disease involving lipid deposition in the cornea resulting in corneal opacification. Primary LK can arise sporadically while secondary LK is seen in patients with a history of ocular trauma, medication exposure, infection,
Majid Moshirfar +6 more
doaj +7 more sources
Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes [PDF]
International Journal of Nanomedicine, 2022 Engy A Abdel Azim,1 Seham A Elkheshen,2,* Rania M Hathout,3,* Marwa A Fouly,4 Nada M El Hoffy1 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Future University in Egypt, New Cairo, Cairo, 11835, Egypt ...
Abdel Azim EA +4 more
doaj +7 more sources
Effect of brimonidine tartrate on basophil activation in glaucoma patients [PDF]
International Journal of Ophthalmology, 2020 AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity. METHODS: A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to a control group consisting 13 ...
Eldar Rosenfeld +7 more
doaj +6 more sources
The role of brimonidine tartrate gel in the treatment of rosacea [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2015 J Mark Jackson,1 Melissa Knuckles,2 John Paul Minni,3 Sandra Marchese Johnson,4, Kevin Tate Belasco5 1Division of Dermatology, University of Louisville, Louisville, KY, USA; 2PSC, Dermatology, Corbin, KY, USA; 3Waters Edge Dermatology, Stuart, FL, USA ...
Jackson JM +4 more
doaj +6 more sources
Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics [PDF]
Frontiers in Medicine, 2023 AimsTo investigate the differences between 0.2 and 0.15% brimonidine tartrate eye drops for anti-mydriatic effects and the optical quality under different light conditions.MethodsThis prospective study involved 80 consecutive high myopia patients ...
Jing Yang +6 more
doaj +5 more sources
Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study [PDF]
PLoS ONE, 2022 Purpose To evaluate the concentrations of brimonidine and timolol in the vitreous and aqueous humors after instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution.
Yusuke Orii +7 more
doaj +6 more sources
Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial [PDF]
Scientific Reports, 2023 This multicenter (four institutions), randomized, investigator-masked, parallel-group clinical trial evaluated and compared the efficacy and safety of preservative-free and preserved brimonidine tartrate 0.15% in open-angle glaucoma and ocular ...
Ko Eun Kim +4 more
doaj +5 more sources
Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate [PDF]
Case Reports in Ophthalmological Medicine, 2020 The aim of this study is to report a patient with corneal opacity that developed after the use of topical antiglaucoma medications other than brimonidine tartrate (BT).
Yuka Kasuya +3 more
doaj +6 more sources
The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations [PDF]
BMC Pharmacology and Toxicology, 2020 Background The study aimed to evaluate and compare the leukocyte chemotactic activities of various brimonidine tartrate (BT) eye drop formulations. Methods A 96-well dot-blot platet using a Boyden-style well was used to study the chemotactic effects of ...
Ruiz Simonato Alonso +4 more
doaj +7 more sources
Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops [PDF]
GMS Ophthalmology Cases, 2020 Objective: We report three cases of preterm neonates who presented with central nervous system (CNS) and respiratory depression after inadvertent exposure to brimonidine tartrate 0.2% and timolol maleate 0.5% fixed-combination ophthalmic drops.Case ...
Azarcon, Corrina P., Santiago, Darby E.
doaj +4 more sources